| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/06/1994 | EP0604418A1 Isolated viral protein cytokine antagonists |
| 07/06/1994 | EP0604409A1 Compositions and methods for detecting and modulating rna activity and gene expression |
| 07/06/1994 | EP0579747A4 Method of modulating mammalian t-cell response |
| 07/06/1994 | EP0374157B1 A new class of low calorie protein sweeteners |
| 07/06/1994 | EP0324788B1 Peptide fragment capable of binding to laminin |
| 07/06/1994 | EP0216854B1 Monoclonal antibodies and assay |
| 07/06/1994 | EP0205475B1 Recombinant methods for production of serine protease inhibitors and dna sequences useful for same |
| 07/06/1994 | CN1088986A Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 07/06/1994 | CN1088936A Peg-interferon conjugates |
| 07/06/1994 | CN1025350C Method for promoting formation of inner molecular disulfide bond of recombination protein in solution of denaturing agent |
| 07/05/1994 | US5326860 Pituitary adenylate cyclase activating protein precursor |
| 07/05/1994 | US5326859 DNA and recombinant plasmid |
| 07/05/1994 | US5326751 Enkephalin analogs |
| 07/05/1994 | US5326749 Macrophage activating factor from vitamin D binding protein |
| 07/05/1994 | US5326700 DNA sequences encoding t-PA derivatives with cleavable sites |
| 07/05/1994 | US5326695 Platelet derived growth factor agonists |
| 07/05/1994 | US5326694 Process for synthesizing human H2-prorelaxin, human H2-relaxin and fusion proteins thereof |
| 07/05/1994 | US5326580 Heat resistant protein with long-lasting taste |
| 07/05/1994 | US5326562 Glycosaminoglycan preservation; arthritis |
| 07/05/1994 | US5326559 Treatment of accelerated atheosclerosis with interleukin-2 receptor targeted molecules |
| 07/05/1994 | US5326558 Megakaryocytopoietic factor |
| 07/05/1994 | CA2112652A1 New transdominant tat variants for hiv virus |
| 07/01/1994 | EP0724633A4 Recombinant transferrins, transferrin half-molecules and mutants thereof |
| 07/01/1994 | CA2112527A1 Mechanism-based screen for retinoid x receptor agonists and antagonists |
| 07/01/1994 | CA2112445A1 Method for monitoring pesticide resistance |
| 07/01/1994 | CA2086577A1 Potential target for immunotherapy to prevent replication of hiv (aids virus) in humans: cdna and protein for a putative regulator of hiv gag polyprotein expression reconstructed from the antisense strand of human p53 gene |
| 07/01/1994 | CA2086576A1 Potential target for an immunotherapeutic approach to stop parkinson's disease in humans: cdna and protein structure for a putative activator of human dopamine receptor and human brain ca2+ channel protein reconstructed from the antisense strand of the human app gene |
| 06/30/1994 | CA2112314A1 Process for production of cell cultures with elevated content of endogenous cytokines |
| 06/29/1994 | EP0604224A1 Porcine GRF receptor |
| 06/29/1994 | EP0604182A2 Inhibitors of HIV protease useful for the treatment of Aids |
| 06/29/1994 | EP0603735A2 Monoclonal antibodies that define a unique antigen of human B-cell antigen receptor complex |
| 06/29/1994 | EP0603672A2 Process for the production of recombinant and synthetic peptides and their use |
| 06/29/1994 | EP0603671A2 Process of reactivating purified membrane proteins |
| 06/29/1994 | EP0603406A1 Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same |
| 06/29/1994 | EP0603399A1 Endothelin-antagonizing peptide |
| 06/29/1994 | EP0603393A1 Recombinant human interleukin 6 with homogeneous n-terminus and production thereof |
| 06/29/1994 | EP0603386A1 Parenteral immunization against rotavirus |
| 06/29/1994 | EP0603337A1 Erythropoietin potentiating agents and methods for their use |
| 06/29/1994 | EP0603312A1 Novel gaba a? receptor with steroid binding sites |
| 06/29/1994 | EP0603309A1 Peptide isoters containing a heterocycle as h.i.v. inhibitors |
| 06/29/1994 | EP0603307A1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same |
| 06/29/1994 | EP0603216A1 Biocidal proteins |
| 06/29/1994 | EP0603194A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 06/29/1994 | EP0603187A1 Human lactoferrin |
| 06/29/1994 | EP0576476A4 Immunoassay for detection of mutant p53 polypeptide in biological fluids |
| 06/29/1994 | EP0564460A4 An augmented western blot format and immunoassay for detection of viral antibodies |
| 06/29/1994 | EP0514416B1 Bacterial peptide fraction with an immunostimulatory effect, process for making it and its use |
| 06/29/1994 | EP0470183B1 Fibroblast growth factor conjugates |
| 06/29/1994 | EP0406272B1 Production of insulin-like growth factor binding protein |
| 06/29/1994 | EP0354923B1 Method for labelling antibodies with a metal ion |
| 06/29/1994 | EP0245362B1 Synthetic peptides and use for diagnosis and vaccination for aids and arc |
| 06/29/1994 | CN1088616A Method for producing large latent transforming growth factor-beta (LL-TGF beta) complexes and constructs useful therefor and method for producing large latency associated peptide (L-LAP) |
| 06/28/1994 | US5324823 Adsorbent for cellular fibronectin and a method for fractional purification of fibronectin |
| 06/28/1994 | US5324820 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| 06/28/1994 | US5324819 Protein produced by expression of DNA cell containing a pair of polypeptide chains disulfide bonded to form dimeric species having less then 200 amino acid; used for grafting in mammals |
| 06/28/1994 | US5324818 Proteins containing DNA or RNA sequences which control gene expression |
| 06/28/1994 | US5324775 Bound to a synthetic non-immunogenic hydrophilic polyethylene glycol polymer; can be injected into humans to augment soft tissue |
| 06/28/1994 | US5324731 Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated |
| 06/28/1994 | US5324715 Protein for inhibiting collagen-stimulated platelet aggregation |
| 06/28/1994 | US5324708 Non-hygroscopic monoammonium salts of phosphonic and phosphinic acids |
| 06/28/1994 | US5324664 Geneically engineered vaccines for cats |
| 06/28/1994 | US5324660 Deficient in proteolytic activity; useful as hosts for expression of proteolytically sensitive recombinant products |
| 06/28/1994 | US5324658 Media for cell growth and method for making them |
| 06/28/1994 | US5324655 Human Y-interferon signal peptide-tumor necrosis factor(TNF) gene fusions |
| 06/28/1994 | US5324654 Method for reversibly increasing proliferation of a non-malignant cell population |
| 06/28/1994 | US5324643 By interfering with one or more of the infection processes including retroviral replication and assembly into infective viral particles |
| 06/28/1994 | US5324641 DNA sequences encoding insulin precursors and methods of production |
| 06/28/1994 | US5324640 Human B-cell differentiation factor and process of producing said factor |
| 06/28/1994 | US5324639 Culture product; genetic expression |
| 06/28/1994 | US5324638 Brain transcription factor, nucleic acids encoding same and uses thereof |
| 06/28/1994 | US5324628 Use of chymotrypsin for the inactivation of prekallikrein activator |
| 06/28/1994 | US5324614 Toner image removal fixed onto support |
| 06/28/1994 | US5324524 Yeast derived mitogen |
| 06/28/1994 | US5324513 Composition useful for the fabrication of vaccines |
| 06/28/1994 | US5324511 Contain a single flagellar (H) antigen of serotype a or a combination with an antigen of serotype b; inhibit motility of pathogens |
| 06/28/1994 | US5324510 Use of antibodies to intercellular adhesion molecule-1 (ICAM-1) in the treatment of asthma |
| 06/28/1994 | US5324508 Applying monokine produced by culturing mammalian macrophage cells to inhibit fibroblast growth in healing wounds |
| 06/28/1994 | US5324351 For coating drug and food products |
| 06/28/1994 | CA1330425C Baculovirus expression system capable of producing foreign gene proteins at high levels |
| 06/28/1994 | CA1330420C Compositions containing growth hormone peptide fragments |
| 06/24/1994 | CA2112193A1 Process for preparing recombinant and synthetic peptides, and their use |
| 06/24/1994 | CA2112192A1 Process for reactivating purified membrane proteins |
| 06/24/1994 | CA2111668A1 Process for the recovery of .alpha.-lactalbumin and .beta.-lactoglobulin from a whey protein product |
| 06/24/1994 | CA2086136A1 Dna probes for the detection of arbuscular endomycorrhizal fungi |
| 06/23/1994 | WO1994014070A1 Immunoassay for the measurement of collagen cleavage in cartilage |
| 06/23/1994 | WO1994014067A1 Diagnosis and therapy of sarcoidosis |
| 06/23/1994 | WO1994013825A2 A disease resistance gene from maize as a selectable marker and gene identification probe |
| 06/23/1994 | WO1994013823A1 Nucleotide sequence for treating cancer and infection |
| 06/23/1994 | WO1994013819A1 Expression system for producing apolipoprotein ai-m |
| 06/23/1994 | WO1994013818A1 Identification of compounds modulations protein/cell membrane association |
| 06/23/1994 | WO1994013817A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 06/23/1994 | WO1994013815A1 Dna encoding chitin deacetylase |
| 06/23/1994 | WO1994013812A2 Novel entomopoxvirus genes, proteins and methods of use thereof |
| 06/23/1994 | WO1994013811A1 New polypeptides, nucleic acid sequences encoding them, and their use to prevent the adhesion of f107-fimbriated bacteria |
| 06/23/1994 | WO1994013810A1 A proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 06/23/1994 | WO1994013809A1 Developmental regulation in anther tissue of plants |
| 06/23/1994 | WO1994013808A2 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 06/23/1994 | WO1994013807A1 Clotting inhibitor made from protostomia saliva |
| 06/23/1994 | WO1994013803A1 Dna sequence encoding the cpg-1 neural polypeptide and the polypeptide encoded thereby |
| 06/23/1994 | WO1994013802A1 D4 gene and methods of use thereof |